VitaSpring Biomedical Co. Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of VitaSpring Biomedical Co. Ltd. generated cash of $0, which is less than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2017 | -4.04K | 0 | 4.6K |
|---|---|---|---|
| 2018 | 401 | -2.24K | 6.5K |
| 2019 | -34.24K | 0 | 29.14K |
| 2020 | -105 | 0 | 0 |
| 2021 | -42.13K | 0 | 87.52K |
| 2022 | 84.81K | -72.99K | 50K |
| 2023 | 0 | 0 | 0 |
VSBC Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 107.21K | 45.39K | 0 | 105 | 5.20K | 555 | -3 |
Operating activities | |||||||
Net income | 0 | 1.26M | -425.38K | 6.91K | -22.39K | -6.37K | -45 |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 0 | 8.36K | 0 | 450 | 450 | 375 | 0 |
Stock-based compensation expense | 0 | 167.17K | 434.21K | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 167.17K | 434.21K | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | -2.95M | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 144K | -144K | 8.49K | -2.68K | -5.81K | 0 |
Accounts payable | 0 | 1.25M | 0 | 0 | -1.41K | 1.41K | 0 |
Cash generated by operating activities | 0 | 84.81K | -42.13K | -105 | -34.24K | 401 | -4.04K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -72.99K | 0 | 0 | 0 | -2.24K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -72.99K | 0 | 0 | 0 | -2.24K | 0 |
Financing activities | |||||||
Common Stock Issued | 0 | 50K | 82.34K | 0 | 18.89K | 0 | 3K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -3.49K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 10.25K | 0 | 1.6K |
Cash used in financing activities | 0 | 50K | 87.52K | 0 | 29.14K | 6.5K | 4.6K |
Net Change In Cash | 0 | 61.81K | 45.39K | -105 | -5.10K | 4.65K | 555 |
Cash at end of period | 107.21K | 107.21K | 45.39K | 0 | 105 | 5.20K | 555 |
| Data source | Data source | Data source | Data source | Data source |